Lithium is a mood-stabilizing medication used to treat bipolar disorder; in AP Psychology it's the classic example of a biological treatment that reduces the intensity of manic episodes and evens out the swings between mania and depression (Topic 8.9).
Lithium is a mood stabilizer, a category of psychoactive medication used primarily to treat bipolar disorder. People with bipolar disorder cycle between manic episodes (elevated mood, racing thoughts, impulsive behavior, little need for sleep) and depressive episodes. Lithium's job isn't to lift mood up or bring it down. It flattens the extremes in both directions, which is why it gets its own category instead of being lumped in with antidepressants.
For AP purposes, lithium lives in Topic 8.9, Treatment of Disorders from the Biological Perspective. The biological perspective says psychological disorders come from physical causes like neurotransmitter imbalances, so the fix is also physical, meaning medication. Lithium is the go-to example of matching a drug class to a disorder. If the question says bipolar disorder and asks for a medication, lithium (or 'mood stabilizers' generally) is the answer the exam wants.
Lithium falls under Topic 8.9, Treatment of Disorders from the Biological Perspective, in Unit 8 (Clinical Psychology). The exam expects you to match major drug categories to the disorders they treat, and lithium-for-bipolar is one of the cleanest pairings on that list. It also reinforces the bigger Unit 8 idea that how you explain a disorder shapes how you treat it. If you explain bipolar disorder biologically (brain chemistry, genetics), the logical treatment is a chemical one. That perspective-to-treatment logic shows up constantly in both multiple choice and FRQ scenarios.
Antidepressants (Unit 8)
Antidepressants like SSRIs lift mood in one direction, which is risky for bipolar patients because it can push them into mania. Lithium stabilizes in both directions, which is exactly why it gets its own drug category on the exam.
Manic Episode (Unit 8)
You can't explain why lithium works without knowing what it's working against. A manic episode is the high-energy, impulsive, euphoric pole of bipolar disorder, and reducing its intensity is lithium's main job.
Biological Perspective (Units 1 & 8)
Lithium is the biological perspective in action. If disorders come from brain chemistry, treatment should target brain chemistry. That same logic links Unit 1's biological bases of behavior to Unit 8's drug therapies.
Antipsychotic Drugs (Unit 8)
Antipsychotics treat schizophrenia by blocking dopamine, while lithium treats bipolar disorder by stabilizing mood. The exam loves swapping these in answer choices, so keep the disorder-to-drug pairing straight.
Lithium shows up most often in matching-style multiple choice questions. A stem describes a patient with both depressive and manic episodes, or directly names bipolar disorder, and asks which medication stabilizes their mood swings. The answer is lithium or, more generally, a mood stabilizer. You may also see it framed conceptually, like explaining how lithium treats bipolar disorder according to the biological perspective. Here the move is to tie the drug to the perspective's logic, meaning the disorder has a chemical or biological cause, so a chemical intervention treats it. No released FRQ has required lithium by name, but it's a strong example for any FRQ asking you to apply a biological treatment to a clinical scenario.
Antidepressants (like SSRIs) push mood upward to treat depression. Lithium is a mood stabilizer that evens out both highs and lows, which is what bipolar disorder requires. If the scenario mentions only depression, think antidepressants. If it mentions mania or swings between mania and depression, think lithium. Picking an antidepressant for a bipolar patient is the classic wrong answer choice.
Lithium is a mood stabilizer used to treat bipolar disorder by reducing the intensity of manic episodes and smoothing the swings between mania and depression.
Lithium belongs to Topic 8.9, Treatment of Disorders from the Biological Perspective, alongside antidepressants, anti-anxiety drugs, and antipsychotics.
Lithium is not an antidepressant; antidepressants lift mood in one direction, while lithium stabilizes mood in both directions.
If an exam question describes a patient cycling between manic and depressive episodes, the medication answer is lithium or a mood stabilizer.
Lithium illustrates the core logic of the biological perspective, which holds that disorders rooted in brain chemistry should be treated with chemical interventions.
Lithium is a mood-stabilizing medication used to treat bipolar disorder. It works by reducing the intensity of manic episodes and evening out mood swings between mania and depression, making it the textbook example of a biological treatment in Topic 8.9.
No. Antidepressants like SSRIs raise mood to treat depression, while lithium is a mood stabilizer that flattens both the manic highs and depressive lows of bipolar disorder. The AP exam treats these as separate drug categories.
Bipolar disorder. Any exam scenario describing a patient with both manic and depressive episodes is pointing you toward lithium or mood stabilizers as the medication answer.
Lithium stabilizes mood and treats bipolar disorder, while antipsychotics treat schizophrenia by blocking dopamine activity. Both are biological treatments in Topic 8.9, but they target different disorders, and the exam tests whether you can keep the pairings straight.
The biological perspective views bipolar disorder as rooted in brain chemistry, so treatment means chemically stabilizing the brain. Lithium does this by dampening the extreme neural activity behind manic episodes, keeping mood within a more normal range.